Bacterial vaginosis (BV) is not officially classified as a sexually transmitted disease, but sex is one of the most common triggers for it. That distinction matters because BV behaves differently from classic STIs like chlamydia or gonorrhea. It’s not caused by a single infectious organism passed between partners. Instead, it’s a shift in the balance of bacteria that naturally live in the vagina, and sexual activity happens to be one of the things that can set off that shift.
Why BV Isn’t Classified as an STI
A sexually transmitted infection, by definition, is caused by a specific pathogen that passes from one person to another during sex. BV doesn’t fit that model. It develops when the protective bacteria in the vagina (mainly lactobacillus, which keeps things acidic) get outnumbered by other types of bacteria that thrive in less acidic environments. The result is an overgrowth of bacteria that are normally present in small amounts, not an invasion by a foreign organism.
This is a key reason medical authorities don’t categorize BV alongside infections like HIV, chlamydia, or syphilis. People who have never had sex can develop BV, though it’s far more common among sexually active women. The CDC and WHO both describe BV in terms of a bacterial imbalance rather than an infection transmitted between partners.
How Sex Triggers BV
Even though BV isn’t an STI, sexual activity is strongly linked to it. The most straightforward explanation involves pH. A healthy vagina is acidic, typically between 3.8 and 4.5 on the pH scale. Semen is alkaline and can raise vaginal pH to 7.0 or higher after unprotected intercourse. That temporary spike creates conditions where BV-associated bacteria can flourish and begin to crowd out protective lactobacillus.
Once those bacteria gain a foothold, they lower the oxidation-reduction potential in the vagina, which further suppresses lactobacillus and allows even more anaerobic bacteria to multiply. It becomes a self-reinforcing cycle: the initial disruption makes it easier for additional problematic bacteria to grow, which makes conditions even less hospitable for the protective bacteria that would normally keep them in check.
Other factors that can trigger BV include douching, having a new sexual partner, having multiple partners, and anything else that disrupts the vaginal microbiome. But unprotected sex is consistently one of the strongest risk factors in research.
What BV Feels Like
About half of women with BV have no symptoms at all. When symptoms do appear, the most recognizable one is a thin, grayish-white discharge with a strong fishy odor, particularly noticeable after sex. Some women also experience mild itching or burning during urination, though BV is generally less irritating than a yeast infection.
BV is typically diagnosed through a pelvic exam and lab evaluation of vaginal discharge. Your provider checks for the characteristic odor, discharge consistency, pH level, and the presence of certain cells under a microscope. It’s a quick process, and results are often available during the same visit.
Does Your Partner Need Treatment?
This is where the “not an STI” classification has real practical consequences. Current guidelines do not recommend routinely treating male sexual partners. A large phase 3 clinical trial tested whether giving a seven-day course of antibiotics to male partners of women with recurrent BV would reduce recurrence. It didn’t. Women whose male partners stuck closely to the antibiotic regimen were slightly less likely to experience treatment failure, but overall, partner treatment did not prevent BV from coming back.
The picture is somewhat different for female sexual partners. BV-associated bacteria can be shared between women, and research suggests concordance in vaginal microbiomes between female partners is common. If you’re in a relationship with another woman and experiencing recurrent BV, it’s worth discussing partner treatment with your provider, even though there aren’t definitive guidelines yet.
BV Raises Your Risk of Actual STIs
One of the most important things to understand about BV is that while it isn’t an STI itself, having it makes you more vulnerable to contracting real STIs. The CDC specifically notes that BV increases your chances of getting or transmitting HIV, as well as infections like chlamydia and gonorrhea. The reason is straightforward: the protective acid-producing bacteria that BV displaces are part of your body’s first line of defense against incoming pathogens. When that barrier is weakened, sexually transmitted organisms have an easier time establishing infection.
This is one of the strongest arguments for treating BV even when symptoms are mild or absent. Getting the vaginal microbiome back to a lactobacillus-dominant state restores a natural layer of protection that matters beyond BV itself.
Treatment and Recurrence
BV is treated with prescription antibiotics, either taken orally or applied as a vaginal gel or cream. Treatment courses typically last five to seven days, and symptoms usually improve within a few days of starting. The antibiotics target the anaerobic bacteria responsible for the overgrowth while sparing lactobacillus, allowing the natural balance to reestablish itself.
Recurrence is the frustrating reality of BV. Roughly half of women who are successfully treated will experience BV again within 12 months. This is partly because the underlying conditions that disrupted the microbiome in the first place, whether related to sexual activity, hygiene habits, or individual biology, often persist. Some women go through repeated cycles of treatment and recurrence for years.
Reducing recurrence risk involves the same factors that reduce initial risk: avoiding douching, using condoms (which prevent semen from raising vaginal pH), and being aware that new sexual partners are a common trigger. Probiotics marketed for vaginal health are widely available, but evidence that they meaningfully prevent BV recurrence remains limited.
The Bottom Line on Classification
BV occupies an awkward middle ground. It’s not sexually transmitted in the traditional sense, since no single organism passes between partners to cause it. But sex is one of the most reliable ways to trigger it, and the bacteria involved can be shared between sexual partners. The WHO includes BV management within its sexually transmitted infections treatment guidelines, even while acknowledging it isn’t technically an STI. For practical purposes, think of BV as a condition that is strongly associated with sexual activity without being caused by it in the way chlamydia or herpes is. That distinction shapes everything from whether your partner needs treatment to how you approach prevention.